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iAlmost 40 years ago, K. Lance Gould proposed the
concept of coronary flow reserve (CFR) to quantify
the effect of epicardial narrowings on myocardial
blood flow (1). CFR represents the extent to which
hyperemic coronary flow can increase above resting
flow. These animal experiments still constitute the
basis for our understanding of coronary physiology.
The development of flow velocity catheters (2,3),
progress in positron emission tomography–derived
absolute flow measurements (4), and, more recently,
transthoracic Doppler flow velocity measurements
(5) extended Gould’s findings into patients with
See page 1079
coronary artery disease. Until the description of
fractional flow reserve became available (6,7), CFR
was the only index commonly used in the clinical
field. Yet, the main problem with CFR in clinical
practice resides in its lack of specificity for the
epicardial vessel: a too-low CFR value does not
determine whether this abnormal flow velocity re-
lates to the epicardial stenosis, to microvascular
disease, or to a combination of both. In addition,
the cutoff value for separating normal from abnor-
mal is actually a moving target and is influenced by
a large variety of factors such as blood pressure,
heart rate, resting flow (which is difficult to obtain
in a patient in a catheterization or echocardiography
laboratory), myocardial mass, and age.
Despite these limitations for individual clinical
decision making, Cortigiani et al. (8) report in this
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Both authors have reported that they have no relationships relevant to the
contents of this paper to disclose.ssue of iJACC an impressive relationship between
ransthoracic Doppler velocity-derived coronary
ow in the left anterior descending artery (LAD)
nd mortality. Grouches will observe that obtaining
eliable flow velocity tracings in the LAD is not
lways possible, especially during maximal hyper-
mia. And, indeed, the authors do not report on the
easibility of the method. Raising 1 eyebrow, others
ill wonder what colleagues would think of a
AD-only angiogram or of a chest radiograph
isplaying only the left hemithorax.
The take-home message of this paper (8) is not a
ragmatic one about individual clinical decision
aking and treatment strategies on the basis of
ransthoracic Doppler flow velocity measurement in
he LAD. The findings of Cortigiani et al. (8)
llustrate a more conceptual finding: when the
daptation of flow to hyperemic stimuli is nor-
al—be it only in the LAD—patients’ prognosis is
xcellent and much better than when CFR is
bnormal. This is not new information, but it is an
mportant confirmation using a noninvasive, cheap,
nd radiation-free methodology.
The first conclusion of the authors (8) (i.e.,
bnormal CFR or ischemia is associated with a
orse prognosis) is only scarcely supported by their
ata. A number of important issues remain, includ-
ng a surprisingly high annual death rate of 10%.
o details are provided on the type of revascular-
zation or the extent of the coronary lesions or their
eft ventricular function. Only 61% of patients who
ad ischemia underwent revascularization. Were
he other 39% considered too high-risk for revas-
ularization? This would explain the high mortality.
s it not surprising that revascularization did not
eem to influence prognosis since functional infor-
ation was present in all patients? Recent data
ndicate that, when properly selected, patients do
ndeed benefit from revascularization (9).
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1087The second conclusion (i.e., normal CFR goes
along with a good prognosis) is well supported by
the present data. A normal noninvasive test result
has been shown repeatedly to be associated with a
very favorable prognosis, regardless of the coronary
anatomy (10). More recently, Muller et al. (11)
reported that in patients with an isolated, angio-
graphically defined stenosis in the proximal LAD
but a fractional flow reserve 0.80, patients’ sur-
vival was similar to that of an age- and gender-
matched control population. In the current study
(8), only 9% of patients with CFR 2 had to
undergo revascularization. Thus, the survival rate
can be considered to reflect, to some extent, the
natural history of this group of patients.
There are many hypotheses regarding the link
between ischemia and mortality. Repeated episodes
of ischemia may alter left ventricular function and
trigger arrhythmias. Alternatively, stress-induced
ischemia might well be an (almost) innocent by-
stander rather than the direct cause. In this hypoth-
esis, ischemia would only be indicative of abnormal
resistance in the epicardial arteries, much like
smoke behind a car is not the cause of the problemcoronary flow reserve with transtho- al. Fractional flowwith a low CFR may induce stress-related ischemia
because the autoregulatory mechanisms cannot
compensate for the abnormal epicardial resistance.
Myocardial autoregulatory mechanisms maintain
blood flow at the cost of a pressure gradient. This
pressure gradient is the trigger for a number of
physical forces that may contribute to plaque desta-
bilization: turbulences, abnormal shear stress, high
and localized plaque stress, slicing forces and tor-
sions, intraplaque gradients, and Venturi effects. In
contrast, in case of nonsignificant stenosis, CFR
will be (near) normal, the gradient will be small or
absent, and these physical forces will remain absent.
These physical phenomena do not appear when
there is no gradient. This may help explain why the
absence of stress-induced ischemia and the presence
of a normal CFR are associated with a good
prognosis, as described by Cortigiani et al. (8). No
gradient, no worries.
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